assembly Bill A7521A

2013-2014 Legislative Session

Authorizes pharmacists to perform collaborative drug therapy management

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

do you support this legislation?

You must fill out the form below in order to support or oppose this bill. X

You must login or fill out the fields below for the senator to have an accurate account of the support or opposition to this bill.

Your valid home address is used to determine which NY State Senator Represents you.
Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.
Use this box to enter a message to your senator.

Actions

view actions (4)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
May 13, 2014 print number 7521a
amend and recommit to higher education
Jan 08, 2014 referred to higher education
May 23, 2013 referred to higher education

Co-Sponsors

Multi-Sponsors

A7521 - Details

Current Committee:
Law Section:
Education Law
Laws Affected:
Amd §6801-a, Ed L; amd §5, Chap 21 of 2011

A7521 - Summary

Authorizes pharmacists to perform collaborative drug therapy management.

A7521 - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  7521

                       2013-2014 Regular Sessions

                          I N  A S S E M B L Y

                              May 23, 2013
                               ___________

Introduced by M. of A. McDONALD -- read once and referred to the Commit-
  tee on Higher Education

AN  ACT  to  amend the education law, in relation to authorizing pharma-
  cists to perform collaborative drug therapy management, and  to  amend
  chapter  21 of the laws of 2011 amending the education law relating to
  authorizing pharmacists to perform collaborative drug therapy  manage-
  ment  with  physicians in certain settings, in relation to making such
  provisions permanent

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 6801-a of the education law, as added by chapter 21
of the laws of 2011, is amended to read as follows:
  S   6801-a.   Collaborative  drug  therapy  management  [demonstration
program].  1. As used in this section, the following  terms  shall  have
the following meanings:
  a.  "Collaborative drug therapy management" shall mean the performance
of services by a pharmacist  relating  to  the  review,  evaluation  and
management  of  drug  therapy  to  a  patient, who is being treated by a
physician OR NURSE PRACTITIONER for a specific disease or disease state,
in accordance with a written agreement or protocol  with  a  voluntarily
participating physician OR NURSE PRACTITIONER and in accordance with the
policies,  procedures,  and protocols of the facility. Such agreement or
protocol as entered into by the physician OR NURSE  PRACTITIONER  and  a
pharmacist, may include, and shall be limited to:
  (i)  adjusting  or managing a drug regimen of a patient, pursuant to a
patient specific written order or protocol made by the patient's  physi-
cian  OR  NURSE PRACTITIONER, which may include adjusting drug strength,
frequency of administration or route of  administration.  Adjusting  the
drug  regimen  shall  not  include substituting or selecting a different
drug which differs from  that  initially  prescribed  by  the  patient's
physician  OR  NURSE  PRACTITIONER unless such substitution is expressly

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD10244-01-3

Co-Sponsors

Multi-Sponsors

A7521A (ACTIVE) - Details

Current Committee:
Law Section:
Education Law
Laws Affected:
Amd §6801-a, Ed L; amd §5, Chap 21 of 2011

A7521A (ACTIVE) - Summary

Authorizes pharmacists to perform collaborative drug therapy management.

A7521A (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7521--A

                       2013-2014 Regular Sessions

                          I N  A S S E M B L Y

                              May 23, 2013
                               ___________

Introduced  by M. of A. McDONALD, WEPRIN, RA -- Multi-Sponsored by -- M.
  of A. BRENNAN, SCHIMEL -- read once and referred to the  Committee  on
  Higher  Education  -- recommitted to the Committee on Higher Education
  in accordance with Assembly Rule 3, sec. 2  --  committee  discharged,
  bill  amended,  ordered  reprinted  as amended and recommitted to said
  committee

AN ACT to amend the education law, in relation  to  authorizing  pharma-
  cists  to  perform collaborative drug therapy management, and to amend
  chapter 21 of the laws of 2011 amending the education law relating  to
  authorizing  pharmacists to perform collaborative drug therapy manage-
  ment with physicians in certain settings, in relation to  making  such
  provisions permanent

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 6801-a of the education law, as added by chapter 21
of the laws of 2011, is amended to read as follows:
  S  6801-a.    Collaborative  drug  therapy  management  [demonstration
program].    1.  As used in this section, the following terms shall have
the following meanings:
  a.  "CLINICAL SERVICES" SHALL MEAN THE REVIEW, EVALUATION AND  MANAGE-
MENT OF DRUG THERAPY TO A PATIENT.
  B.  "Collaborative drug therapy management" shall mean the performance
of CLINICAL services by a pharmacist relating to the review,  evaluation
and  management  of drug therapy to a patient, who is being treated by a
physician, PHYSICIAN ASSISTANT OR  NURSE  PRACTITIONER  for  a  specific
disease  or  disease [state] STATES, in accordance with a written agree-
ment or protocol with a voluntarily participating  physician,  PHYSICIAN
ASSISTANT,  NURSE  PRACTITIONER  OR  FACILITY and in accordance with the
policies, procedures, and protocols of [the]  A  facility  OR  PRACTICE.
Such  agreement  or protocol as entered into by the physician, PHYSICIAN

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD10244-03-4

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.